7/16/24
CBSA has consistently advocated for PBM reform at the state and federal level. Following the release of an interim report from the Federal Trade Commission (FTC) blasting the business practices of “prescription drug middlemen” and news reports that the FTC is preparing to sue the three largest pharmacy benefit managers (PBMs), CBSA is continuing to urge Congress to take action addressing middlemen in the drug supply chain.
We encourage CBSA members to join CBSA in signing onto a letter to Congresswoman Diana DeGette urging her to support H.R.2880, the “Protecting Patients Against PBM Abuses Act,” which we expect to be marked up in the House Oversight and Investigations Subcommittee on July 23. To see the draft letter and sign on, please email Amy Goodman. CBSA will need logos to add to the letter by the end of day on Thursday, July…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
